Saturday 17 October 2026
Export MTVA’s income statement to Excel — free account
MetaVia Inc.
MTVA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 68.5% and free cash flow fell 22.4%, each against the same quarter a year earlier.
1.26
0.11
−8.03%
Follow MTVA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (175.68%) | (195.12%) | (195.61%) | (168.18%) |
+8 more TTM periods Free account |
|
| (91.06%) | (99.00%) | (94.75%) | (87.87%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(214.68%) | (146.13%) | (247.39%) | (260.12%) | |
Free Cash Flow per Share |
(2.67) | (3.12) | (8.89) | (7.35) | |
Free Cash Flow |
(15.83) | (15.14) | (15.70) | (16.31) | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
(81.39%) | (66.41%) | (100.59%) | (79.15%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.10 | 1.15 | 1.21 | 1.01 | |
Depreciation/Fixed assets |
2.38 | 1.67 | 1.12 | 0.86 | |
Capex/Depreciation |
0.00 | 0.00 | (0.11) | (0.11) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.67) | (3.12) | (8.89) | (7.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates